Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -216.05% is 143% below its 5-year average of -88.95%, near the low end of its 5-year range (-216.05%–-32.74%).
As of the fiscal period ended Tuesday, June 30, 2026. 28.68% below its 12-month average of -167.90%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -216.05%.
RETURN ON INVESTED CAPITAL (ROIC)
-216.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-167.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-104.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-88.95%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-28.68%
CURRENT VS 3Y AVG
-107.34%
CURRENT VS 5Y AVG
-142.88%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-505.86%
vs the sector median at left
Neumora Therapeutics, Inc. Common Stock
Market Cap
$87.27M
Return on Invested Capital (ROIC)
-216.05%
TTM Avg
-167.90%
3Y Avg
-104.20%
5Y Avg
-88.95%
Market Cap
$87.85M
Return on Invested Capital (ROIC)
-100.35%
TTM Avg
-639.99%
3Y Avg
-358.78%
5Y Avg
-266.51%
Market Cap
$87.96M
Return on Invested Capital (ROIC)
12.79%
TTM Avg
17.38%
3Y Avg
-11.40%
5Y Avg
-8.36%
Market Cap
$85.86M
Return on Invested Capital (ROIC)
-111.42%
TTM Avg
-65.09%
3Y Avg
-48.38%
5Y Avg
-36.92%
Market Cap
$89.44M
Return on Invested Capital (ROIC)
-217.73%
TTM Avg
-143.58%
3Y Avg
-163.00%
5Y Avg
-133.51%
Market Cap
$89.78M
Return on Invested Capital (ROIC)
-34.10%
TTM Avg
-61.58%
3Y Avg
-76.39%
5Y Avg
-65.18%
Market Cap
$90.20M
Return on Invested Capital (ROIC)
8.16%
TTM Avg
0.11%
3Y Avg
-4.79%
5Y Avg
-3.69%
Market Cap
$90.37M
Return on Invested Capital (ROIC)
-220.02%
TTM Avg
-209.28%
3Y Avg
-141.42%
5Y Avg
-99.57%
Market Cap
$84.13M
Return on Invested Capital (ROIC)
-109.43%
TTM Avg
-208.02%
3Y Avg
-178.83%
5Y Avg
-203.50%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neumora Therapeutics, Inc. Common Stock (NMRA) | $87.27M | -216.05% | -167.90% | -104.20% | -88.95% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $87.85M | -100.35% | -639.99% | -358.78% | -266.51% |
| CareCloud, Inc. (CCLD)vs › | $87.96M | 12.79% | 17.38% | -11.40% | -8.36% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $85.86M | -111.42% | -65.09% | -48.38% | -36.92% |
| electroCore, Inc. (ECOR)vs › | $89.44M | -217.73% | -143.58% | -163.00% | -133.51% |
| Equillium, Inc. (EQ)vs › | $89.78M | -34.10% | -61.58% | -76.39% | -65.18% |
| ImmuCell Corporation (ICCC)vs › | $90.20M | 8.16% | 0.11% | -4.79% | -3.69% |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | -220.02% | -209.28% | -141.42% | -99.57% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | -109.43% | -208.02% | -178.83% | -203.50% |
| Rallybio Corporation (RLYB)vs › | $90.64M | -24.40% | -73.07% | -65.09% | -50.82% |
ROIC
-216.0%
ROE
-477.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -216.05% |
| 2026-03-31 | -179.83% |
| 2025-12-31 | -151.78% |
| 2025-09-30 | -161.32% |
| 2025-06-30 | -130.53% |
| 2025-03-31 | -120.13% |
| 2024-12-31 | -91.77% |
| 2024-09-30 | -78.13% |
| 2024-06-30 | -60.54% |
| 2024-03-31 | -49.13% |
| 2023-12-31 | -39.95% |
| 2023-09-30 | -32.74% |
| 2023-06-30 | -42.70% |
| 2023-03-31 | -35.27% |
| 2022-12-31 | -33.75% |
| 2022-06-30 | -81.95% |
| 2022-03-31 | -72.65% |
| 2021-12-31 | -58.45% |
| 2021-09-30 | -53.43% |
